EVENTS
See where Litmys is showing up and shaping the conversation. From industry conferences to speaking engagements, this is where we highlight the moments and forums driving forward-looking dialogue.
November 4, 2026
Harris Kaplan to Join Panel on Innovation and Collaboration at Mid-Atlantic Capital Conference 2026
How can startups, investors, and established companies work together to bring innovation to market faster? Litmys Managing Partner Harris Kaplan will share his perspectives at PACT's Mid-Atlantic Capital Conference 2026, joining a panel exploring new approaches to collaboration and the opportunities that arise when commercial considerations are integrated earlier in the innovation process.

November 2, 2026
Litmys to Present with PharmaACE at U.S. Biotech Day 2026
How can biotech companies build more credible commercial forecasts? At U.S. Biotech Day 2026, Harris Kaplan of Litmys and Michael Devinoff of PharmaACE will explore how integrating real-world adoption insights with advanced forecasting can improve development, investment, and commercialization decisions.

October 26, 2026
Harris Kaplan to Attend Advanced Therapies USA 2026
Cell and gene therapies are transforming medicine, but groundbreaking science alone doesn't guarantee commercial success. Harris Kaplan will attend Advanced Therapies USA 2026 in Boston to connect with industry leaders navigating the unique challenges of bringing these innovations to patients.

October 23, 2026
Harris Kaplan Joins Wilson Sonsini's Biotech Summit as Pre-Conference Webinar Speaker and Conference Attendee
From attracting investment to bringing innovative therapies to market, commercial strategy plays a critical role in biotech success. Litmys Managing Partner Harris Kaplan contributed to Wilson Sonsini's 2026 Biotech Summit program as a featured pre-conference webinar speaker and attended the in-person conference in Boston, connecting with innovators, investors, and industry leaders.

October 19, 2026
Harris Kaplan to Attend BioFuture 2026
BioFuture 2026 brings together the innovators and investors shaping the next generation of healthcare. Litmys' Harris Kaplan will join the conversation in New York City, sharing perspectives on how emerging biotech companies can build stronger commercial strategies and more compelling investment stories.

September 14, 2026
Harris Kaplan to Attend LSX Congress USA 2026
Commercial success starts long before launch. Harris Kaplan will represent Litmys at LSX Congress USA 2026 in Boston, connecting with biotech executives, investors, and industry partners to discuss the value of evaluating market potential and adoption barriers earlier in development.



